
Shabna Sulaiman
@drss_neph
Internist with li'l extra know-how about kidneys and infections;
@Glomcon fellow 2021-22.
PGI'ite.
JIPMERite.
Nephrologist at IQRAA, Calicut
ID: 1090748976863813635
30-01-2019 23:09:56
368 Tweet
420 Followers
197 Following

The #EMPA_KIDNEY trial has found that empagliflozin reduces the risk of kidney disease progression or cardiovascular death by 28% in people with #ChronicKidneyDisease bit.ly/3U7L4j8 Boehringer Ingelheim LillyDiabetes Medical Research Council British Heart Foundation Watch an animation about the results ⬇



Shabna Sulaiman . Another publication from our centre indianjnephrol.org/trend-of-antim…



Shabna Sulaiman Transplantation Direct journals.lww.com/transplantatio…
